Inhibition of angiogenesis-relevant receptor tyrosine kinases by Sulindac analogues

ChemBioChem

Volumn 6, Issue 3, 2005, Pages 527-531

  Gourzoulidou, Eleni ^a   Carpintero, Mercedes ^a   Baumhof, Patrick ^b   Giannis, Athanassios ^b   Waldmann, Herbert ^a  

^a MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Angiogenesis; Combinatorial chemistry; Kinase inhibitors; Medicinal chemistry; Sulindac

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOPOIETIN RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN TYROSINE KINASE; SOMATOMEDIN C RECEPTOR; SULINDAC; SULINDAC SULFIDE; SULINDAC SULFONE; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3; DRUG DERIVATIVE;

ANGIOGENESIS; ARTICLE; DRUG MECHANISM; DRUG STRUCTURE; ENZYME INHIBITION; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION INITIATION; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; IC 50; METABOLISM; SYNTHESIS;

ANGIOGENESIS INHIBITORS; INHIBITORY CONCENTRATION 50; MOLECULAR STRUCTURE; RECEPTOR PROTEIN-TYROSINE KINASES; SULINDAC;

EID: 20444478308     PISSN: 14394227     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbic.200400192     Document Type: Article

References (37)

1. J. R. Vane, Nature (London) New Biol. 1971, 231, 232-235.
2. R. N. Dubois, S. B. Abramson, L. Crofford, R. A. Gupta, FASEB J. 1998, 12, 1063-1073.
3. D. W. Coyne, M. Nickols, W. Bertrand, A. R. Morrison, Am. J. Physiol. 1992, 263, F97-102.
4. D. L. Simmons, D. B. Levy, Y. Yannoni, R. L. Erikson, Proc. Natl. Acad. Sci. USA 1989, 86, 1178-1182.
5. S. M. Prescott, R. M. White, Cell 1996, 87, 783-786.
6. B. S. Reddy, C. V. Rao, K. Seibert, Cancer Res. 1996, 56, 4566-4569.
7. C. V. Rao, A. Rivenson, B. Simi, E. Zang, G. Kelloff, V. Steele, B. S. Reddy, Cancer Res. 1995, 55, 1464-1472.
8. K. J. Mukamal, M. A. Mittleman, M. Maclure, J. B. Sherwood, R. J. Goldberg, J. E. Muller, Am. Heart J. 1999, 137, 1120-1128.
9. L. A. Garcia Rodriguez, C. Varas, C. Patrono, Epidemiology 2000, 11, 382-387.
10. E. T. Goluboff, Expert Opin. Invest. Drugs 2001, 10, 1875-1882.
11. T.-C. He, T. A. Chan, B. Vogelstein, K. W. Kinzler, Cell 1999, 99, 335-345.
12. I. Tegeder, J. Pfeilschifter, G. Geisslinger, FASEB J. 2001, 15, 2057-2072.
13. M. K. Jones, H. Wang, B. M. Peskar, E. Lewin, R. M. Itani, I. J. Sarfeh, A. S. Tarnawski, Nature Med. 1999, 5, 1418-1423.
14. J. Folkman, Semin. Cancer Biol. 2003, 13, 159-167.
15. a) J. Folkman, Nat. Med. 1995, 1, 27-31;
16. b) A. Giannis, F. Rübsam, Angew. Chem. 1997, 109, 606-609;
17. Angew. Chem. Int. Ed. Engl. 1997, 36, 588-590.
18. a) J. Folkman, N. Engl. J. Med. 1971, 285, 1182-1186;
19. b) P. Carmeliet, R. K. Jain, Nature 2000, 407, 249-257.
20. a) G. D. Yancopoulos, S. Davis, N. W. Gale, J. R. Rudge, S. J. Wiegand, J. Holash, Nature 2000, 407, 249-257;
21. b) P. C. Maisonpierre, C. Suri, P. F. Jones, S. Bartunkova, S. J. Wiegand, C. Radziejewski, D. Compton, J. McClain, T. H. Aldrich, N. Papadopoulos, T. J. Daly, S. Davis, T. N. Sato, G. D. Yancopoulos, Science 1997, 277, 55-60.
22. S. Hiratsuka, Y. Maru, A. Okada, M. Seiki, T. Noda, M. Shibuya, Cancer Res. 2001, 61, 1207-1213.
23. H. Kubo, T. Fujiwara, L. Jussila, H. Hashi, M. Ogawa, K. Shimizu, M. Awane, Y. Sakai, A. Takabayashi, K. Alitalo, Y. Yamaoka, S. I. Nishikawa, Blood 2000, 96, 546-553.
24. A. Stratmann, T. Acker, A. M. Burger, K. Amann, W. Risau, K. H. Plate, Int. J. Cancer 2001, 91, 273-282.
25. S. A. Stacker, C. Caesar, M. E. Baldwin, G. E. Thornton, R. A. Williams, R. Prevo, D. G. Jackson, S. Nishikawa, H. Kubo, M. G. Achen, Nat. Med. 2001, 7, 186-191.
26. M. Skobe, T. Hawighorst, D. G. Jackson, R. Prevo, L. Janes, P. Velasco, L. Riccardi, K. Alitalo, K. Claffey, M. Detmar, Nat. Med. 2001, 7, 192-198.
27. P. Lin, J. A. Buxton, A. Acheson, C. Radziejewski, P. C. Maisonspierre, G. D. Yancopoulos, K. M. Channon, L. P. Hale, M. W. Dewhirst, S. E. George, K. G. Peters, Proc. Natl. Acad. Sci. USA 1998, 95, 8829-8834.
28. J. Drevs, I. Hofmann, H. Hugenschmidt, C. Wittig, H. Madjar, M. Muller, J. Wood, G. Martiny-Baron, C. Linger, D. Marme, Cancer Res. 2000, 60, 4819-4824.
29. C. Rosenbaum, P. Baumhof, R. Mazitschek, O. Müller, A. Giannis, H. Waldmann, Angew. Chem. 2004, 116, 226-230;
30. Angew. Chem. Int. Ed. 2004, 43, 224-228.
31. O. Müller, E. Gourzoulidou, M. Carpintero, I.-M. Karaguni, A. Langerak, C. Herrmann, T. Möröy, L. Klein-Hitpaß, H. Waldmann, Angew. Chem. 2004, 116, 456-460;
32. Angew. Chem. Int. Ed. 2004, 43, 450-454.
33. H. Waldmann, I.-M. Karaguni, M. Carpintero, E. Gourzoulidou, C. Herrmann, C. Brockmann, H. Oschkinat, O. Müller, Angew. Chem. 2004, 116, 460-464;
34. Angew. Chem. Int. Ed. 2004, 43, 454-458.
35. M. J. Ellis, S. Jenkins, J. Hanfelt, M. E. Redington, M. Taylor, R. Leek, K. Siddle, A. Harris, Breast Cancer Res. Treat. 1998, 52, 175.
36. A. Grothey, W. Voigt, C. Schober, T. Muller, W. Dempke, H. J. Schmoll, J. Cancer Res. Clin. Oncol. 1999, 125, 166-173.
37. V. Kirkin, R. Mazitschek, J. Krishnan, A. Steffen, J. Waltenberger, M. S. Pepper, A. Giannis, J. P. Sleeman, Eur. J. Biochem. 2001, 268, 5530-5540.